Wednesday, November 8, 2017

Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

 2017 Nov 1;41(6):688-691. doi: 10.7399/fh.10877.

Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.

Author information

1
Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid.Hospital Virgen de las Nieves - Farmacia. mangel.calleja.sspa@juntadeandalucia.es.
2
Servicio de Farmacia, Clínica Universidad de Navarra, Grupo de trabajo PkGen de la SEFH, Pamplona.. mangel.calleja.sspa@juntadeandalucia.es.
3
Servicio de Farmacia, Hospital Universitario Virgen de Macarena, Sevilla.. mangel.calleja.sspa@juntadeandalucia.es.
4
Servicio de Anatomía Patológica, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBiS)/CSIC/Universidad de Sevilla, Sevilla. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII.. mangel.calleja.sspa@juntadeandalucia.es.
5
Servicio de Farmacia, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela.. mangel.calleja.sspa@juntadeandalucia.es.
6
Servicio de Oncología Médica, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII.. mangel.calleja.sspa@juntadeandalucia.es.
7
Servicio de Anatomía Patológica y Genética Molecular, Hospital Universitari de Bellvitge, IDIBELL, Hospital Universitari Arnau de Vilanova, Universidad de Lleida, IRBLLEIDA, Lleida. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII.. mangel.calleja.sspa@juntadeandalucia.es.
8
Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal. IRYCIS. Universidad de Alcalá, Madrid. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII.. jose.palacios@salud.madrid.org.
9
Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Pamplona.. jmartin@mustbesevilla.org.

Abstract

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology (SEOM), Pathology (SEAP), and Hospital Pharmacy (SEFH) we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.

No comments:

Post a Comment